Patient experience with fentanyl effervescent buccal tablets: Interim analysis of a long-term study in patients with cancer-related breakthrough pain.

被引：0

作者：

Rhiner, M

Kerr, C

Lamarre, D

Messina, J

Slatkin, N

机构：

[1] Univ Calif Los Angeles, City Hope Canc Ctr, Duarte, CA USA

[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA

来源：

ONCOLOGY NURSING FORUM | 2006年 / 33卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

233

引用

页码：460 / 461

页数：2

共 50 条

[1] Long-term tolerability of fentanyl effervescent buccal tablets: Interim analysis in patients with cancer-related breakthrough pain.
Slatkin, N.
Charu, V.
Niebler, G.
Rauck, R.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 484S - 484S
[2] Finding an appropriate dose of fentanyl effervescent buccal tablets for relief of cancer-related breakthrough pain.
Weick, J. K.
Tremmel, L.
Messina, J.
Portenoy, R. K.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 484S - 484S
[3] Fentanyl buccal tablet for the treatment of cancer-related breakthrough pain
Mercadante, Sebastiano
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 9 - 13
[4] A randomized, placebo-controlled study of fentanyl effervescent buccal tablets for breakthrough pain in opioid-tolerant patients with cancer.
Manco, L
Messina, J
Portenoy, R
ONCOLOGY NURSING FORUM, 2006, 33 (02) : 455 - 455
[5] Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
Prommer, Eric
Ficek, Brandy
PATIENT PREFERENCE AND ADHERENCE, 2012, 6
[6] Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study
Zeppetella, G
PALLIATIVE MEDICINE, 2001, 15 (04) : 323 - 328
[7] Long-term safety tolerability, and acceptability of fentanyl pectin nasal spray in the treatment of breakthrough cancer pain.
Burton, A. W.
Gabrail, N. Y.
Radbruch, L.
Taylor, D.
Reyes, E.
Portenoy, R.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[8] Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Cancer Pain A Long-term, Open-Label Safety Study
Weinstein, Sharon M.
Messina, John
Xie, Fang
CANCER, 2009, 115 (11) : 2571 - 2579
[9] Fentanyl Buccal Tablets for Breakthrough Pain in Highly Tolerant Cancer Patients: Preliminary Data on the Proportionality Between Breakthrough Pain Dose and Background Dose
Mercadante, Sebastiano
Ferrera, Patrizia
Adile, Claudio
Casuccio, Alessandra
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 42 (03) : 464 - 469
[10] Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients
Nalamachu, S. R.
Narayana, A.
Janka, L.
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 751 - 760

← 1 2 3 4 5 →